Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zabofloxacin in Community-Acquired Pneumonia
NCT01081964Phase 2Terminated
- Sponsor
- IASO Pharma Inc.
- Start
- Mar 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zabofloxacin in community acquired pneumonia (CAP), sponsored by IASO Pharma Inc.. Started Mar 2010; status: terminated.
02
Drugs
zabofloxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT01081964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081964.